Medical Equipment

GMP Cell Therapy Consumables Market Performance and Future Outlook at 26.6% CAGR Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gmp cell therapy consumables market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The GMP Cell Therapy Consumables Industry By 2029?

The gmp cell therapy consumables market size has experienced significant growth in recent years. This market is anticipated to expand from $17.85 billion in 2024 to $22.73 billion in 2025, achieving a compound annual growth rate (CAGR) of 27.3%. The historic growth can be linked to expanding investments in regenerative medicine, developments in cell therapy research, numerous clinical trials and subsequent approvals, the growing occurrence of chronic diseases, and an increasing understanding of personalized medicine.

The gmp cell therapy consumables market size is projected to experience significant growth in the coming years. It is expected to reach $58.46 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 26.6%. This expansion over the forecast period is driven by the broadening of cell therapy applications, a global rise in cell therapy trials, supportive regulatory environments for cell therapies, the development of advanced cell therapy platforms, and the worldwide spread of cell therapy manufacturing. Key trends during this period include investments in manufacturing infrastructure, technological advancements in cell processing, the establishment of collaborations and partnerships, enhanced digitalization and data integration, and strategic alliances and mergers.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp

What Major Drivers Are Impacting The GMP Cell Therapy Consumables Market?

An anticipated increase in drug discovery is set to fuel the expansion of the GMP cell therapy consumables market. This process involves identifying new potential medicines through the integration of computational, experimental, translational, and clinical approaches. Significant progress in areas such as molecular biology, genetics, bioinformatics, and high-throughput screening methods has transformed drug discovery. Such technologies empower researchers to gain a deeper comprehension of disease mechanisms, pinpoint prospective drug targets, and more effectively screen extensive compound libraries for candidate drugs. Consequently, this heightened activity in drug discovery contributes to the growth of the GMP cell therapy consumables market. As an illustration, the Food and Drug Administration, a US-based federal agency of the Department of Health and human services, reported in January 2023 that FDA’s Centre for Drug Evaluation and Research (CDER) in the US approved 37 new drugs and therapeutic biological products in 2022 for diverse medical conditions. Thus, the increasing momentum in drug discovery is a key factor boosting the expansion of the GMP cell therapy consumables market.

Which Segment Categories Are Driving Maximum Growth In The GMP Cell Therapy Consumables Market?

The gmp cell therapy consumablesmarket covered in this report is segmented –

1) By Product: Kits, Reagents Or Molecular Biology reagents, Growth Factors Or Cytokines And Interleukins, Other Products

2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies

3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation, Cell Distribution Or Handling, Process Monitoring And Control Or Readministration Or Quality Assurance, Other Processes

4) By End-Use: Clinical, Commercial, Research

Subsegments:

1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits

2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents

3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Antibody Cytokines, Immunomodulatory Cytokines

3) By Other Products: Cell Culture Vessels, Bioreactors, Media And Supplements

Which Long-Term Trends Will Play A Crucial Role In The GMP Cell Therapy Consumables Market?

Leading companies in the GMP cell therapy consumables market are actively developing GMP-compliant CD34+ hematopoietic stem cells (HSCs) to support advanced therapeutic applications. These GMP-compliant CD34+ hematopoietic stem cells (HSCs) are characterized as a specific type of stem cell that exhibits the CD34 marker on its exterior and is manufactured under Good Manufacturing Practice (GMP) conditions. For example, in April 2024, OrganaBio, a pharmaceutical company located in the US, unveiled HematoPAC-HSC-CB-GMP, which offers an on-demand supply of GMP-compliant CD34+ hematopoietic stem cells (HSCs) derived from fresh human cord blood. OrganaBio applies its profound experience in cell isolation and GMP manufacturing to achieve high yields of highly viable CD34+ HSCs within 24 hours of collection. This recent launch is intended to expedite the creation of next-generation therapies, particularly those targeting blood cancers and various genetic disorders.

Who Are The Dominant Players In The GMP Cell Therapy Consumables Market Today?

Major companies operating in the GMP cell therapy consumables market include Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Merck KGaA, Asahi Kasei Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Avantor Inc., Lonza Group AG, Terumo Corporation, Catalent Inc., Sartorius AG, Bio-Techne Corp, Repligen Corporation, Miltenyi Biotec BV & Co KG, Genscript Biotech Corporation, Rentschler Biopharma SE, FUJIFILM Irvine Scientific Inc., BioLegend Inc., STEMCELL Technologies Inc., BioLife Solutions Inc., Abzena Ltd., Sino Biological Inc., ProBioGen AG, MaxCyte Inc., PromoCell GmbH, PeproTech Inc., Cellares Corp., Wilson Wolf Corporation, Cellexus Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

Which Region Is At The Forefront Of Innovation In The GMP Cell Therapy Consumables Market?

North America was the largest region in the GMP cell therapy consumables market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the GMP cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12014&type=smp

Browse Through More Reports Similar to the Global GMP Cell Therapy Consumables Market 2025, By The Business Research Company

Aerospace Coatings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aerospace-coatings-global-market-report

Paints And Coatings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/paints-and-coatings-global-market-report

Water Borne Coatings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/water-borne-coatings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795